Papers
9
Total Citations
187
H-Index
5
About
Dr. Wutang Jing is a pioneering surgeon-researcher whose work sits at the intersection of robotic surgery, minimally invasive oncology, and telemedicine. His primary research focus is the comparative efficacy and safety of robotic-assisted versus laparoscopic techniques for gastrointestinal and hepatobiliary cancers. Dr. Jing’s most influential work includes a landmark 2018 meta-analysis on robotic cholecystectomy (77 citations) and a pivotal 2020 meta-analysis of randomized controlled trials comparing robotic and laparoscopic proctectomy for rectal cancer (52 citations). These studies have helped define best practices in minimally invasive surgery. He has also made significant contributions to gastric cancer surgery, demonstrating the feasibility of the da Vinci robot using a novel “3+2” mode. Most notably, Dr. Jing is at the forefront of surgical innovation, leading early pilot studies on 5G remote robot-assisted gastrectomy and telerobotic cholecystectomy—work that promises to expand access to specialized surgical care across vast distances. With a growing body of work that bridges rigorous evidence synthesis and cutting-edge technology, Dr. Jing is shaping the future of surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9